Clinical Trial Update: 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This Phase 3 open-label, randomized 2-way crossover multicentre trial evaluated the safety and efficacy of HOE901 insulin analogue given at bedtime plus lispro …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• HOE901 Insulin Analogue (insulin analogue HOE901)
• NPH insulin (insulin isophane)
• Regular insulin (insulin)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED